Aurora Cannabis (ACB) Accounts Payables (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Accounts Payables of $36.9 million for Q1 2026, down 28.08% year-over-year from $51.3 million in Q1 2025, and down 24.37% quarter-over-quarter from $48.8 million in Q4 2025.
Aurora Cannabis (ACB) Accounts Payables (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Accounts Payables for 9 consecutive years, with $36.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables fell 28.08% year-over-year to $36.9 million; the TTM figure through Mar 2026 stood at $36.9 million (down 28.08% YoY), while the FY2026 annual figure was $36.9 million, down 30.32% from the prior year.
- Accounts Payables eased to $36.9 million in Q1 2026 per ACB's latest filing, from $48.8 million in the prior quarter.
- Across five years, Accounts Payables topped out at $74.1 million in Q3 2022 and bottomed at $28.6 million in Q3 2024.
- Historically, Accounts Payables has averaged $47.2 million across 5 years, with a median of $46.5 million in 2023.
- Annual changes were most pronounced in 2022 — Accounts Payables jumped 71.03% — and 2023, when it plunged 48.97%.
- Aurora Cannabis' Accounts Payables stood at $56.2 million in 2022, then declined by 18.49% to $45.8 million in 2023, then climbed by 9.39% to $50.1 million in 2024, then decreased by 2.59% to $48.8 million in 2025, then slipped by 24.37% to $36.9 million in 2026.
- Business Quant data shows ACB's Accounts Payables at $36.9 million in Q1 2026, $48.8 million in Q4 2025, and $35.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 356.00 Mn |
| 10 | Aurora Cannabis | 232.22 Mn | 159.91 Mn | 25.75 Mn | 41.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.89 Mn |
| Dec 31, 2025 | 48.78 Mn |
| Sep 30, 2025 | 35.86 Mn |
| Jun 30, 2025 | 58.67 Mn |
| Mar 31, 2025 | 51.30 Mn |
| Dec 31, 2024 | 50.08 Mn |
| Sep 30, 2024 | 28.61 Mn |
| Jun 30, 2024 | 37.93 Mn |
| Mar 31, 2024 | 43.46 Mn |
| Dec 31, 2023 | 45.78 Mn |
| Sep 30, 2023 | 37.82 Mn |
| Jun 30, 2023 | 46.51 Mn |
| Mar 31, 2023 | 52.71 Mn |
| Dec 31, 2022 | 56.17 Mn |
| Sep 30, 2022 | 74.12 Mn |
| Jun 30, 2022 | 54.81 Mn |
| Mar 31, 2022 | 42.62 Mn |
| Dec 31, 2021 | 41.89 Mn |
| Sep 30, 2021 | 43.34 Mn |
| Jun 30, 2021 | 47.14 Mn |